104 related articles for article (PubMed ID: 3488030)
1. [Induction of a cytotoxic factor into the peritoneal fluid (PCF) by OK-432. II. Physicochemical and immunological characteristics of PCF].
Nagamuta M; Yamamoto A; Usami H; Sugawara Y; Nishii Y; Watanabe N; Niitsu Y; Urushizaki I
Gan To Kagaku Ryoho; 1986 Jul; 13(7):2358-62. PubMed ID: 3488030
[TBL] [Abstract][Full Text] [Related]
2. [Induction of mouse peritoneal cytotoxic factor by OK-432. (3). Comparison between LPS and OK-432 as eliciting agents].
Yamamoto A; Nagamuta M; Usami H; Sugawara Y; Nishii Y; Suzuki S; Watanabe N; Niitsu Y; Urushizaki I
Gan To Kagaku Ryoho; 1986 Jul; 13(7):2419-24. PubMed ID: 3729496
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a cytotoxic factor induced in mouse peritoneal fluid by OK-432.
Nagamuta M; Yamamoto A; Usami H; Sugawara Y; Watanabe N; Niitsu Y; Urushizaki I
Immunol Lett; 1986 Aug; 13(1-2):101-5. PubMed ID: 3759145
[TBL] [Abstract][Full Text] [Related]
4. [Production of a cytotoxic factor in mouse peritoneal fluid by OK-432, a streptococcal preparation].
Yamamoto A; Nagamuta M; Usami H; Sugawara Y; Watanabe N; Niitsu Y; Urushizaki I
Gan To Kagaku Ryoho; 1986 May; 13(5):1905-10. PubMed ID: 3707150
[TBL] [Abstract][Full Text] [Related]
5. Release of tumor necrosis factor (TNF) into mouse peritoneal fluids by OK-432, a streptococcal preparation.
Yamamoto A; Nagamuta M; Usami H; Sugawara Y; Watanabe N; Niitsu Y; Urushizaki I
Immunopharmacology; 1986 Apr; 11(2):79-86. PubMed ID: 3710767
[TBL] [Abstract][Full Text] [Related]
6. [Induction of tumor necrosis factor (TNF) by OK-432].
Watanabe N; Sone H; Neda H; Niitsu Y; Urushizaki I
Gan No Rinsho; 1984 Aug; 30(10):1290-2. PubMed ID: 6481965
[TBL] [Abstract][Full Text] [Related]
7. Production of cytotoxic factor into mouse peritoneal fluid by OK-432, a streptococcal preparation.
Yamamoto A; Nagamuta M; Usami H; Sugawara Y; Watanabe N; Niitsu Y; Urushizaki I
Immunol Lett; 1985; 11(2):83-8. PubMed ID: 4086064
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effect of OK-432 induced endogenous TNF on tumor bearing mice and cancer patients.
Watanabe N; Niitsu Y; Yamauchi N; Neda H; Sone H; Urushizaki I; Yamamoto A; Nagamuta M; Sugawara Y
Immunopharmacol Immunotoxicol; 1988; 10(1):53-65. PubMed ID: 3361071
[TBL] [Abstract][Full Text] [Related]
9. [Anticancer effects of OK-432 (2). Anticancer actions of M phi activated by OK-432].
Saito M; Aonuma E; Noda T; Nakadate I; Nanjo M; Ebina T; Ishida N
Gan To Kagaku Ryoho; 1983 May; 10(5):1363-71. PubMed ID: 6870302
[TBL] [Abstract][Full Text] [Related]
10. [Definition of tumor-necrosis factor and its production mechanism].
Urushizaki I; Niitsu Y; Watanabe N
Gan To Kagaku Ryoho; 1984 Jul; 11(7):1356-68. PubMed ID: 6378100
[TBL] [Abstract][Full Text] [Related]
11. Priming effect of interferons and interleukin 2 on endogenous production of tumor necrosis factor in mice.
Satoh M; Shimada Y; Inagawa H; Minagawa H; Kajikawa T; Oshima H; Abe S; Yamazaki M; Mizuno D
Jpn J Cancer Res; 1986 Apr; 77(4):342-4. PubMed ID: 2422147
[TBL] [Abstract][Full Text] [Related]
12. Augmentation by OK-432 of generation of culture-induced killer cells.
Ujiie T
Jpn J Exp Med; 1987 Jun; 57(3):153-61. PubMed ID: 3682231
[TBL] [Abstract][Full Text] [Related]
13. Impaired induction of type II interferon in tumor-bearing mice.
Matsubara S; Suzuki M; Ishida N
Cancer Res; 1980 Mar; 40(3):873-6. PubMed ID: 6162555
[TBL] [Abstract][Full Text] [Related]
14. [Antitumor effect of OK-432 (3)--mechanisms of tumor growth inhibition by OK-432 induced activated macrophages].
Nanjo M; Saito M; Aonuma E; Fujimura H; Nakamura T; Aso H; Yoshie O; Ebina T; Ishida N
Gan To Kagaku Ryoho; 1985 Apr; 12(4):887-93. PubMed ID: 3885861
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of a Streptococcus pyogenes preparation (OK-432). II. Analysis of the cytotoxic lymphocytes induced by OK-432 injection into tumor-bearing F344 rats.
Fukui H; Reynolds CW
J Natl Cancer Inst; 1987 Nov; 79(5):1019-24. PubMed ID: 3500354
[TBL] [Abstract][Full Text] [Related]
16. Induction of tumor necrosis factor by administration of OK-432 in cancer patients.
Kokunai I; Shimano T; Sekimoto K; Takeda T; Kobayashi T; Yayoi E; Yamamoto A; Mori T
J Clin Lab Immunol; 1986 Dec; 21(4):169-71. PubMed ID: 3560194
[TBL] [Abstract][Full Text] [Related]
17. Soluble and membrane-bound TNF-alpha are involved in the cytotoxic activity of B cells from tumor-bearing mice against tumor targets.
Lopez-Cepero M; Garcia-Sanz JA; Herbert L; Riley R; Handel ME; Podack ER; Lopez DM
J Immunol; 1994 Apr; 152(7):3333-41. PubMed ID: 8144919
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic effect of endogenous tumor necrosis factor on ascites Meth A sarcoma.
Watanabe N; Niitsu Y; Sone H; Neda H; Urushizaki I; Yamamoto A; Nagamuta M; Sugawara Y
J Immunopharmacol; 1986; 8(2):271-83. PubMed ID: 3722836
[TBL] [Abstract][Full Text] [Related]
19. Production of tumor necrosis factor (TNF) by monocytes from cancer patients and healthy subjects induced by OK-432 in vitro, and its augmentation by human interferon gamma.
Sekimoto M; Kokunai I; Shimano T; Kobayashi T; Takeda T; Haruna N; Yamamoto A; Mori T
J Clin Lab Immunol; 1988 Nov; 27(3):115-20. PubMed ID: 3150012
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of a Streptococcus pyogenes preparation (OK-432). I. Sequential effector mechanisms following a single OK-432 injection in F344 rats leading to the rejection of syngeneic MADB106 tumor cells.
Fukui H; Reynolds CW
J Natl Cancer Inst; 1987 Nov; 79(5):1011-7. PubMed ID: 3479632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
